title: Perinatal HIV: special considerations.
abstract: The percentage of AIDS cases among women--particularly women of color--in the United States is increasing yearly. Despite this increase, there has been a relatively steady decline in the number of AIDS cases occurring perinatally. Regardless of the reasons HIV-infected couples choose to become pregnant, studies indicate that providing support, such as contraceptive counseling and assisted reproduction techniques, can improve the health outcome in the face of HIV-related challenges. Issues specific to antiretroviral therapy, including viral resistance, pregnancy outcomes, and adverse fetal effects, complicate the treatment of perinatal HIV. Postpartum case is yet another area that requires special consideration when supporting HIV-infected parents and children. The growing body of data on pregnancy and HIV may indicate a rising commitment to research of and support for the unique challenges HIV-infected families face. This article was adapted from an IAS-USA interactive case-based program, Cases on the Web, in November 2003.
authors.affiliation: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California-San Francisco, San Francisco, CA, USA.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohan
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000635:transmission*; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D008297:Male; D018743:Perinatal Care; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000188:drug therapy; D011256:Pregnancy Outcome; D011322:Primary Prevention / Q000379:methods; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
chemical_list: D019380:Anti-HIV Agents